Logo for Helius Medical Technologies Inc.
HSM

Helius Medical Technologies Inc.

Status
Delisted
Industry
Issued & Outstanding63,104,788
Reserved for Issuance12,314,400
Currency
CSE Index

About

Helius Medical Technologies Inc.

Listing date
June 23, 2014

Helius Medical Technologies Inc., through its wholly-owned subsidiary NeuroHabilitation Corporation, is dedicated to developing products that treat neurological symptoms caused by disease or trauma. The Company's Portable Neuro-modulation Stimulator ("PoNS") device that shows anecdotal promise is making it through the clinical trial process for the treatment of balance disorder in patients who suffered a traumatic brain injury ("TBI") or from neurological disease.